Cingulate Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Cingulate Inc. (CING) reported Increase (Decrease) in Prepaid Expense and Other Assets of $719.85 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$199.63K, a 155.69% decline year-over-year.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $919.49K, a 76.39% increase year-over-year.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$248.70K.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$7.34K, a 100.94% decline year-over-year.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $623.71K.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$88.40K.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.77M, a 404.41% decline from fiscal 2022.
- Cingulate Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $580.59K, a 53.88% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$199.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $719.85K 10-Q · filed 2026-08-13 | $471.15K derived: sum of 3 quarters · filed 2026-08-13 | $463.81K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $919.49K 10-Q · filed 2026-05-14 | $670.79K derived: sum of 2 quarters · filed 2026-05-14 | $663.45K derived: sum of 3 quarters · filed 2026-05-14 | $1.02M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$248.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$256.04K derived: sum of 2 quarters · filed 2026-03-18 | $102.43K derived: sum of 3 quarters · filed 2026-08-13 | $623.71K 10-K · filed 2026-03-18 |
| 2025-09-30 | -$7.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $351.13K derived: sum of 2 quarters · filed 2026-08-13 | $872.40K 10-Q · filed 2025-11-13 | -$5.66K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $358.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $879.74K 10-Q · filed 2026-08-13 | $1.69K derived: sum of 3 quarters · filed 2026-08-13 | $784.66K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $521.28K 10-Q · filed 2026-05-14 | -$356.78K derived: sum of 2 quarters · filed 2026-05-14 | $426.19K derived: sum of 3 quarters · filed 2026-05-14 | -$666.33K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$878.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$95.08K derived: sum of 2 quarters · filed 2026-03-18 | -$1.19M derived: sum of 3 quarters · filed 2026-03-18 | -$88.40K 10-K · filed 2026-03-18 |
| 2024-09-30 | $782.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$309.55K derived: sum of 2 quarters · filed 2025-11-13 | $789.66K 10-Q · filed 2025-11-13 | $390.93K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $6.68K 10-Q · filed 2025-08-19 | -$392.05K derived: sum of 3 quarters · filed 2025-08-19 | -$1.13M derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-08 | $700.48K derived: sum of 2 quarters · filed 2025-05-08 | -$41.79K derived: sum of 3 quarters · filed 2025-05-08 | -$371.93K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$398.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$1.14M derived: sum of 2 quarters · filed 2025-03-27 | -$1.47M derived: sum of 3 quarters · filed 2025-03-27 | -$1.77M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$742.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.07M derived: sum of 2 quarters · filed 2024-11-07 | -$1.37M 10-Q · filed 2024-11-07 | -$1.08M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$330.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$626.39K 10-Q · filed 2024-08-13 | -$338.94K derived: sum of 3 quarters · filed 2024-08-13 | -$113.72K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$296.25K 10-Q · filed 2024-05-08 | -$8.80K derived: sum of 2 quarters · filed 2024-05-08 | $216.41K derived: sum of 3 quarters · filed 2024-05-08 | $675.55K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $287.45K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $512.66K derived: sum of 2 quarters · filed 2024-04-01 | $971.81K derived: sum of 3 quarters · filed 2024-04-01 | $580.59K 10-K · filed 2024-04-01 |
| 2022-09-30 | $225.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $684.36K derived: sum of 2 quarters · filed 2023-11-13 | $293.14K 10-Q · filed 2023-11-13 | -$1.29M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $459.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $67.93K 10-Q · filed 2023-08-14 | -$1.52M derived: sum of 3 quarters · filed 2023-08-14 | $136.37K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$391.22K 10-Q · filed 2023-05-10 | -$1.98M derived: sum of 2 quarters · filed 2023-05-10 | -$322.77K derived: sum of 3 quarters · filed 2023-05-10 | $680.35K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $68.44K derived: sum of 2 quarters · filed 2023-03-10 | $1.07M derived: sum of 3 quarters · filed 2023-03-10 | $1.26M 10-K · filed 2023-03-10 |
| 2021-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.66M derived: sum of 2 quarters · filed 2022-11-14 | $2.84M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.19M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $187.29K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $11.61K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |